Praveen Kumar Marimuthu, DM Resident in Medical Oncology at the Christian Medical College and Hospital, shared an article on X:
“Pharmacovigilance alert in NSCLC!
PPIs plu Osimertinib is equal to Elevated Cardiotoxicity risk.
Postmarketing FAERS data links combo to:
- QT prolongation
- Cardiomyopathy
- IHD
- Arrhythmias
- Heart failure
- Avoid PPI.”
Impact of Proton Pump Inhibitors on Osimertinib-Induced Cardiotoxicity in NSCLC Patients.
Authors: Haitao Wang, Sinan Ma, Weijia Huang, Keyu Chen, Jiao Xie, Na Wang, Youjia Li, Qianting Yang, Xin Yang, and Yan Wang.
You can read the full article on Journal of Springer Nature Link.
More posts featuring Praveen Kumar Marimuthu.